Clinical Trial

ARAT for Reflux Disease After Peroral Endoscopic Myotomy in Patients With Achalasia

Study acronym: ARAT
Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated April 25, 2025 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The peroral endoscopic myotomy for the treatment of achalasia is associated with a higher incidence of gastroesophageal reflux disease compared with Heller's myotomy. Remodeling of the esophagogastric junction with hybrid argon plasma could decrease the passage of gastric or gastroduodenal content into the esophagus.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2019-08-20; most recent amendment 2025-04-23.
Trial Details
NCT Number NCT04065516
Lead Sponsor Coordinación de Investigación en Salud, Mexico
Conditions Achalasia, Gastroesophageal Reflux
Enrollment 44 participants
Start Date 2019-07-03
Primary Completion 2026-07-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-04-25